<DOC>
	<DOCNO>NCT01544192</DOCNO>
	<brief_summary>Background : The significance retinal ganglion cell protection glaucoma lead view , glaucomatous optical neuropathy also consider pathology central nervous system . It known α−tocopherol Gingko Biloba specific neuroprotective vasoregulatory activity , addition antioxidant effect . In study , investigator compare early neuroprotective effect α−tocopherol GB well control strong antioxidant formulation patient glaucoma . Methods : In non-randomized control trial , 120 eye 60 patient glaucoma enrol study divide 4 group , consist 30 eye . Unlike control , patient 3 antioxidant group receive α−tocopherol , Gingko Biloba strong antioxidant formula 3 month . Central vision field MD , PSD OCT well thickness retinal nerve fiber layer , ganglion cell count c/d ratio record . The data compare statistically .</brief_summary>
	<brief_title>Impact Oral Versatile Antioxidants Glaucoma Progression</brief_title>
	<detailed_description>A significant difference observe MD , PSD , s-RNFL m-RNFL level group ( p &lt; 0.05 ) ( Table 3 ) , compare Groups Vit E AOF , MD s-RNFL level Group GB significantly low PSD level significantly high group . m-RNFL level Vit E group significantly high m-RNFL level GB , AOF Control group ( p &lt; 0.05 , p &lt; 0.01 ) . In comparison Vitamin E GB , MD value find significantly high PSD value significantly low ( p &lt; 0.05 ) . No statistically significant difference present I-RNFL level group ( p &gt; 0.05 ) . While difference c/d level group highly significant ( p &lt; 0.01 ) ( Table 3 ) , c/d level Vit E GB group find significantly low c/d level AOF Control group ( p &lt; 0.01 ) . c/d level Vit E group significantly low c/d level AOF Control group ( p &lt; 0.01 ) . No statistically significant difference find c/d level group ( p &gt; 0.05 ) . No statistically significant difference present s-GCC i-GCC level group ( p &gt; 0.05 ) . A high statistically significant difference find m-GCC level group ( p &lt; 0.01 ) . While highly 201 significant significant difference present m-GCC level Vit E Group m-GCC level AOF Control Groups , respectively , ( p &lt; 0.01 , p &lt; 0.05 ) , m-GCC level Group GB significantly high Group AOF ( p &lt; 0.05 ) . No statistically significant difference observe m-GCC level group ( p &gt; 0.05 ) .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Patients receive followup glaucoma polyclinics Known ocular systemic concomitant disorder Previous glaucoma surgery Antioxidant usage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Antioxidant</keyword>
	<keyword>α−tocopherol</keyword>
	<keyword>Vitamin E</keyword>
	<keyword>Gingko Biloba</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Retina</keyword>
</DOC>